Clinical Trials Browser

Phase 1/2 × Lymphoma, Large B-Cell, Diffuse × durvalumab × Clear all

NCT03310619 2024-04-04

PLATFORM

Phase 1/2 Completed

62 enrolled 41 charts

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse